Section 26, Surrogacy (Regulation) Act, 2021 [S2A-8KB]

As at 6 September 2026. In force from 18 April 2021 by S.O. 1509(E) [N12-KWG].

In Surrogacy (Regulation) Act, 2021 [A11-R3P]. This text from 18 April 2021. No other text held.

Synthetic. The words of this section are generated by the register; the title, number and year of the Act are real.

Cite: Section 26, Surrogacy (Regulation) Act, 2021 [S2A-8KB]. Machine: S2A-8KB.

26. Prohibition of the manufacture of drugs without licence.—No person shall undertake the manufacture of drugs except under and in accordance with the conditions of a licence granted under section 27: Provided that nothing in this section shall apply to the manufacture of drugs undertaken by or on behalf of the Central Government or a State Government.

Defined terms in this text (2)

drug: Section 2, Surrogacy (Regulation) Act, 2021 [S2A7V2] (In this Act, unless the context otherwise requires,—): "drug" includes all medicines for internal or external use of human beings or animals and all substances intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease or disorder in human beings or animals

drug: 19 more definitions.

manufacture: Section 2, Surrogacy (Regulation) Act, 2021 [S2A7V2] (In this Act, unless the context otherwise requires,—): "manufacture" in relation to any drug, includes any process or part of a process for making, altering, ornamenting, finishing, packing, labelling, breaking up or otherwise treating or adopting any drug with a view to its sale or distribution

manufacture: 36 more definitions.

Made under this section, or naming it (0)

none

Cited by (0)

none

Not held (0)

none

Duties published under this section (0)

none